Source link : https://www.newshealth.biz/health-news/benefits-of-neoadjuvant-immunotherapy-in-breast-cancer-extend-beyond-tnbc/
Neoadjuvant, but not adjuvant, chemoimmunotherapy significantly improved key outcomes in certain patients with early breast cancer, according to a meta-analysis involving more than 5,000 patients. Consistent with existing evidence, the addition of immune checkpoint inhibitors (ICIs) to neoadjuvant chemotherapy improved pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC) by an absolute difference of […]
Author : News Health
Publish date : 2024-08-29 21:17:37
Copyright for syndicated content belongs to the linked Source.
Categories